Skip to main content

VanEck Vectors Pharmaceutical ETF (PPH)

NASDAQ: PPH · IEX Real-Time Price · USD
74.59 0.37 (0.50%)
Oct 22, 2021 4:00 PM EDT - Market closed
Assets$325.66M
NAV$74.21
Expense Ratio0.35%
PE Ratio19.50
Shares Out4.39M
Dividend (ttm)$1.25
Dividend Yield1.68%
Ex-Dividend DateOct 1, 2021
1-Year Return
-
Volume15,222
Open74.34
Previous Close74.22
Day's Range74.19 - 74.59
52-Week Low57.32
52-Week High77.09
Beta0.89
Holdings26
Inception DateFeb 1, 2000

About PPH

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Asset ClassEquity
SectorHealthcare
RegionGlobal
IssuerVan Eck Associates
Stock ExchangeNASDAQ
Ticker SymbolPPH
Index TrackedMVIS US Listed Pharmaceutical 25 Index

Top 10 Holdings

50.10% of assets
NameSymbolWeight
MerckMRK5.48%
AstraZenecaAZN5.41%
Novo Nordisk A/SNVO5.29%
AbbVieABBV5.01%
SanofiSNY4.99%
Novartis AG ADRNVSN.MX4.92%
Eli LillyLLY4.87%
Johnson & JohnsonJNJ4.86%
PfizerPFE4.69%
McKessonMCK4.58%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Oct 1, 2021$0.3453Oct 7, 2021
Jul 1, 2021$0.2859Jul 8, 2021
Apr 1, 2021$0.3497Apr 8, 2021
Dec 29, 2020$0.2662Jan 5, 2021
Oct 1, 2020$0.2493Oct 7, 2020
Jul 1, 2020$0.2523Jul 8, 2020
Full Dividend History

News

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

1 month ago - Zacks Investment Research

Strong Vaccine Demand Lifting Pharma Sales

There are multiple coronavirus vaccines on the market, and with the likelihood of booster shots increasing by the day, the revenue outlook for healthcare exchange traded funds, including the VanEck Vect...

1 month ago - ETF Trends

Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

2 months ago - Zacks Investment Research

Pharma ETFs Gain on Q2 Earnings

Many industry bigwigs reported solid results with some beating on earnings or revenues or both.

Other symbols:FTXHIHEPJPXPH
2 months ago - Zacks Investment Research

Alzheimer's Drug Cost Pushes Pharmaceutical Prices Back Into the Spotlight

Biogen's (NASDAQ: BIIB) Aduhelm sparked a rally in the biotech giant's share price and hope that progress is being made in treating Alzheimer's. However, the news isn't free of controversy, and carries ...

Other symbols:BIIB
2 months ago - ETF Trends

Pharma & Healthcare ETFs at a One-Year High: Here's Why

Upbeat earnings, COVID-19-related sales, compelling valuation and lucrative dividend prospects are boosting pharma and healthcare ETFs.

2 months ago - Zacks Investment Research

Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

4 months ago - Zacks Investment Research

Artificial Intelligence Set to Transform the Pharmaceutical Industry

The pharmaceuticals industry got a boost last year when a Covid-19 vaccine was introduced, but artificial intelligence (AI) could keep the sector and ETFs like the VanEck Vectors Pharmaceutical ETF (PPH...

Other symbols:AI
4 months ago - ETF Trends

Pharma ETFs in Focus Post Q1 Earnings

The slew of Q1 results have led to mixed trading in pharma ETFs over the past month.

Other symbols:FTXHIHEPJPXPH
5 months ago - Zacks Investment Research

7 Pharmaceutical Stocks That Could Get a Covid Hangover

Pharmaceutical stocks gained a lot from the pandemic and the race to vaccines, but most of that upside is off the table now. The post 7 Pharmaceutical Stocks That Could Get a Covid Hangover appeared fir...

Other symbols:IBIOMRNANVAXOCGNSRNE
6 months ago - InvestorPlace

Pharma Goes Beyond the Vaccine. ‘PPH' on the Verge of More Advances

Coming off a vaccine rally that started in the middle of 2020, the pharmaceutical industry will continue to evolve as technological advances make their way into the sector, which should help ETFs like t...

7 months ago - ETF Trends

Pharma ETFs in Focus Post Q4 Earnings

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

Other symbols:FTXHIHEPJPXPH
8 months ago - Zacks Investment Research

ETFs to Tap AstraZeneca Mega-Deal to Buy Alexion

AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.

Other symbols:BBHFBTPBEPJP
10 months ago - Zacks Investment Research

Beyond the Vaccine: The Long Runway for Health and Pharmaceutical ETFs

With 2020 election season in the rearview mirror, it could be a great time to revisit health and pharmaceutical ETFs, including the VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH). PPH tracks the MVIS U...

10 months ago - ETF Trends

Write A Prescription For This Pharma ETF

After scuffling amid political uncertainty leading up to Election Day, pharmaceutical stocks and exchange-traded funds are finally perking amid a spate of encouraging news regarding coronavirus vaccine ...

11 months ago - Benzinga

Pharma Sector Steps up as a Portfolio Prescription

By VanEck Hope Springs Eternal Hopes of a return to normality are increasing after a year of pandemic-induced tumult. News that COVID-19 vaccines developed by Pfizer and BioNTech, and Moderna were more ...

11 months ago - ETF Trends

3 Reasons to Bet on Healthcare ETFs

The broader medical sector should be in the spotlight now on hopes of a coronavirus vaccine and the likelihood of a divided congress.

Other symbols:FTXHPJPPSCHXHSXPH
11 months ago - Zacks Investment Research

Here's Why Healthcare ETFs Are Rallying Post Elections

Easing worries regarding major policy changes are driving the relief rally in the healthcare and biotech spaces in the post-election period.

Other symbols:IBBPJPVHTXBIXLV
11 months ago - Zacks Investment Research

Q3 Earnings Fail to Impress Pharma ETFs

The slew of Q3 results have led to mixed trading in pharma ETFs over the past month.

Other symbols:FTXHIHEPJPXPH
11 months ago - Zacks Investment Research

3 Pet Stocks to Buy for Your Furry Friend

These trio of pets stocks to buy offers global potential for investors looking to play the growing trend of owning a furry friend. The post 3 Pet Stocks to Buy for Your Furry Friend appeared first on I...

Other symbols:MRKPETS
1 year ago - InvestorPlace

Some Good Deals Are Available in Pharmaceuticals ETFs

Investors looking for compelling valuations don’t have to go deep into the lagging value factor. They can harness some growth with pharmaceuticals ETFs, including the VanEck Vectors Pharmaceutical ETF (...

1 year ago - ETF Trends

A Divergence Has Occurred In Healthcare

For the first four months of the market’s cornavirus recovery, one of the key themes was the dominance of biotech.

Other symbols:BBH
1 year ago - Benzinga

Pharma ETFs Soar on Robust Q2 Earnings

Total earnings of 66.4% of the healthcare market capitalization that has reported so far are up 4.4% on revenue growth of 4%.

Other symbols:FTXHIHEPJPXPH
1 year ago - Zacks Investment Research

COVID-19 Vaccine Push Brings Hope: Stock & ETF Beneficiaries

There are at least a hundred candidates in the COVID-19 vaccine race globally. However, few companies like Moderna, Pfizer and AstraZeneca are showing considerable hope.

1 year ago - Zacks Investment Research

Assessing Political Outcomes for Pharmaceuticals ETFs

The VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH) is among the healthcare ETFs recently showing signs of life due in large part to the fight against the coronavirus and although this is an election ye...

1 year ago - ETF Trends